Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–48.
Article CAS PubMed Google Scholar
Hirahara N, Matsubara T, Kaji S, Kawabata Y, Hyakudomi R, Yamamo, et al. Glasgow prognostic score is a better predictor of the long term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score. Oncotarget. 2020;11:4169–77.
Konishi T, Kosuga T, Inoue H, Konishi H, Shiozaki A, Kubota T, et al. Signifcance of Preoperative Prognostic Nutritional Index in the Perioperative Management of Gastric Cancer. J Gastrointest Surg. 2022;26:558–69.
Kuroda D, Sawayama H, Kurashige J, Iwatsuki M, Eto T, Tokunaga R, et al. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018;21:204–12.
Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG. Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma. Ann Surg. 2016;263:292–7.
Müller L, Hahn F, Mähringer-Kunz A, Stoehr F, Gairing SJ, Michel M, et al. Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: evaluation of the CALLY index. Cancers (Basel). 2021;13:5018.
Tsunematsu M, Haruki K, Taniai T, Tanji Y, Shirai Y, Furukawa K, et al. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy. Ann Gastroenterol Surg. 2022;7:503–11.
Article PubMed PubMed Central Google Scholar
Tsai YT, Ko CA, Chen HC, Hsu CM, Lai CH, Lee YC, et al. Prognostic value of CRP-Albumin-Lymphocyte (CALLY) index in patients undergoing surgery for oral cavity cancer. J Cancer. 2022;13:3000–12.
Article CAS PubMed PubMed Central Google Scholar
Iida H, Tani M, Komeda K, Nomi T, Matsushima H, Tanaka S, et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2022;24:101–15.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–112.
Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver.4). Gastric Cancer. 2017;20:1–19.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
Article PubMed PubMed Central Google Scholar
Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89:1028–30.
Article CAS PubMed PubMed Central Google Scholar
Onodera, T.; Goseki, N.; Kosaki, G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 1984;85,:1001–5.
Hooper CE, Lyburn ID, Searle J. The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication. Br J Cancer. 2015;112:1175–82.
Article CAS PubMed PubMed Central Google Scholar
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related infammation. Nature. 2008;454:436–44.
Article ADS CAS PubMed Google Scholar
Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.
Article PubMed PubMed Central Google Scholar
Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361–71.
Article CAS PubMed Google Scholar
Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factorsignalling: live or let die. Nat Rev Immunol. 2015;15:362–74.
Article CAS PubMed Google Scholar
Hirashima K, Watanabe M, Shigaki H, Imamura Y, Ida S, Iwatsuki M, Ishimoto T, et al. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol. 2014;49:1040–6.
Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, Zhang DS, et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumor biology. 2012;33:749–56.
Wakahara T, Ueno N, Maeda T, Kanemitsu K, Yoshikawa T, Tsuchida S, et al. Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers? Gastroenterology Res. 2017;10:359–65.
Article CAS PubMed Google Scholar
Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, et al. The Prognostic Nutritional Index Predicts Long-term Outcomes of Gastric Cancer Patients Independent of Tumor Stage. Ann Surg Oncol. 2013;20:2647–54.
Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275–9.
Article CAS PubMed PubMed Central Google Scholar
Zhao BW, Chen YM, Jiang SS, Chen YB, Zhou ZW, Li YF. Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer. PLoS ONE. 2015;10: e0129531.
Article PubMed PubMed Central Google Scholar
Choi S, Song JH, Lee S, Cho M, Kim YM, Kim HI, et al. Lymphovascular Invasion: Traditional but Vital and Sensible Prognostic Factor in Early Gastric Cancer. Ann Surg Oncol. 2021;28:8928–35.
Comments (0)